Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies
- 18 August 2005
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 13 (1) , 20-28
- https://doi.org/10.1038/sj.gt.3302594
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Delay of muscle degeneration and necrosis in mdx mice by calpain inhibitionMuscle & Nerve, 1999
- Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgeneNature, 1996
- Autosomal recessive limbgirdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ–sarcoglycan geneNature Genetics, 1996
- Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular DystrophyScience, 1995
- β–sarcoglycan: characterization and role in limb–girdle muscular dystrophy linked to 4q12Nature Genetics, 1995
- β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complexNature Genetics, 1995
- Visualization of Dystrophic Muscle Fibers in Mdx Mouse by Vital Staining with Evans Blue: Evidence of Apoptosis in Dystrophin-Deficient MuscleThe Journal of Biochemistry, 1995
- Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophyCell, 1994
- Dystrophin: The protein product of the duchenne muscular dystrophy locusCell, 1987
- Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy geneNature, 1986